Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B K Hamilton

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Nursing Measurement|July 1, 1997
Psychometric evaluation of the Organizational Job Satisfaction ScaleM A Sauter, D Boyle, D Wallace, et al.
The Journal of Antibiotics|January 1, 1977
Microbial reduction of the side-chain carbonyl of daunorubicin and N-acetyldaunorubicinA A Aszalos, N R Bachur, B K Hamilton, et al.
Blood Cancer Journal|August 29, 2015
Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort studyB K Hamilton, L Rybicki, H Haddad, et al.
Bone Marrow Transplantation|July 29, 2014
Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantationB K Hamilton, L Rybicki, J Dabney, et al.
Bone Marrow Transplantation|April 26, 2016
Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphomaS Hong, L Rybicki, D M Abounader, et al.
Bone Marrow Transplantation|October 11, 2016
GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignanciesA Nazha, L Rybicki, D Abounader, et al.
Bone Marrow Transplantation|July 21, 2015
Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantationS Fu, L Rybicki, D Abounader, et al.
Bone Marrow Transplantation|January 5, 2016
Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapyS Hong, J Valent, L Rybicki, et al.
Leukemia|August 19, 2017
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromesA Nazha, K Al-Issa, B K Hamilton, et al.
Bone Marrow Transplantation|June 2, 2015
Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipientsB K Hamilton, A D Law, L Rybicki, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Nursing Measurement|July 1, 1997
Psychometric evaluation of the Organizational Job Satisfaction ScaleM A Sauter, D Boyle, D Wallace, et al.
The Journal of Antibiotics|January 1, 1977
Microbial reduction of the side-chain carbonyl of daunorubicin and N-acetyldaunorubicinA A Aszalos, N R Bachur, B K Hamilton, et al.
Blood Cancer Journal|August 29, 2015
Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort studyB K Hamilton, L Rybicki, H Haddad, et al.
Bone Marrow Transplantation|July 29, 2014
Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantationB K Hamilton, L Rybicki, J Dabney, et al.
Bone Marrow Transplantation|April 26, 2016
Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphomaS Hong, L Rybicki, D M Abounader, et al.
Bone Marrow Transplantation|October 11, 2016
GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignanciesA Nazha, L Rybicki, D Abounader, et al.
Bone Marrow Transplantation|July 21, 2015
Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantationS Fu, L Rybicki, D Abounader, et al.
Bone Marrow Transplantation|January 5, 2016
Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapyS Hong, J Valent, L Rybicki, et al.
Leukemia|August 19, 2017
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromesA Nazha, K Al-Issa, B K Hamilton, et al.
Bone Marrow Transplantation|June 2, 2015
Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipientsB K Hamilton, A D Law, L Rybicki, et al.
Pageof 3